Jci_page_head_homepage_01 Jci_page_head_homepage_02
Christina Schlecker, Wolfgang Boehmerle, Andreas Jeromin, Brenda DeGray, Anurag Varshney, Yogendra Sharma, Klara Szigeti-Buck, Barbara E. Ehrlich
Published in Volume 116, Issue 6
J Clin Invest. 2006; 116(6):1668–1674 doi:10.1172/JCI22466
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 6
Lithium reduces the NCS-1–mediated increase in InsP3 R1 activity.

(A) Addition of lithium (concentrations as indicated) did not alter the ability of NCS-1 to immunoprecipitate InsP3R1. (B) Single-channel recordings of InsP3R1. Traces show the activity in the presence of 300 nM free calcium, 2 μM InsP3, and 2 μg/ml NCS-1 and were recorded after addition of 1 μM, 200 μM, and 1 mM lithium (in the top, middle, and bottom panels, respectively). (C) Averaged values from at least 3 experiments for Po. The concentration dependence for lithium on the NCS-1–mediated enhancement of InsP3R activity in the presence (open circles) and absence (filled circles) of NCS-1. The IC50 for lithium was approximately 350 μM.